Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Ignyta Announces Proposed Public Offering Of Common Stock May 2, 2017 Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility February 7, 2018 The Best Career Advice from Axovant's CEO October 11, 2017